Mannkind (MNKD) EBITDA Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 1,292.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,292.00 |
| Dec 31, 2025 | 2,860.00 |
| Sep 30, 2025 | 5,228.00 |
| Jun 30, 2025 | 682,492.00 |
| Mar 31, 2025 | 20,570.00 |
| Dec 31, 2024 | 22,602.00 |
| Sep 30, 2024 | 4,788.00 |
| Jun 30, 2024 | 6,707.00 |
| Mar 31, 2024 | 6,074.00 |
| Dec 31, 2023 | 14,220.00 |
| Sep 30, 2023 | 6,942.00 |
| Jun 30, 2023 | 396,104.00 |
| Mar 31, 2023 | 2,910.00 |
| Dec 31, 2022 | 3,551.00 |
| Sep 30, 2022 | 122,487.00 |
| Jun 30, 2022 | -134,200.00 |
| Mar 31, 2022 | -9,980.00 |
| Dec 31, 2021 | -14,330.00 |
| Sep 30, 2021 | 45,238.00 |
| Jun 30, 2021 | 48,341.00 |
| Mar 31, 2021 | 73,762.00 |
| Dec 31, 2020 | 50,782.00 |
| Sep 30, 2020 | 131,982.00 |
| Jun 30, 2020 | -249,791.00 |
| Mar 31, 2020 | 60,758.00 |
| Dec 31, 2019 | 2,442.00 |
| Sep 30, 2019 | -132,696.00 |